Ultragenyx Pharmaceutical Inc.

RARE

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001515673

SEC filings (opens in a new tab)

In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 4 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Ultragenyx Pharmaceutical Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of RARE: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	243	1	221	−21
Shares	69.5M	583.0K	70.6M	+1.66M (+2.4%)
Value	$3.21B	$26.9M	$2.52B	−$662.3M (−20.8%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to RARE in Q3 2023
Institution	Shares	Value	% of portfolio
Pictet Asset Management Holding SA	869,388	$31.0M	0.04%
Bank of Nova Scotia	42,451	$1.51M	0.00%
Y-Intercept (Hong Kong) Ltd	15,442	$550.5K	0.05%
Group One Trading, L.P.	5,693	$203.0K	0.01%
Quarry LP	4,200	$149.7K	0.10%
KBC Group NV	1,584	$56.0K	0.00%
Cutler Group LP	1,010	$36.0K	0.01%
Clear Street Markets LLC	657	$23.0K	0.02%
Northwestern Mutual Wealth Management Co	100	$3.56K	0.00%
Central Trust Co	24	$856	0.00%
Massmutual Trust Co FSB	18	$642	0.00%

Sold out (32)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of RARE in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Capital International Investors	967,357	$44.6M
HRT Financial LP	59,300	$2.73M
Teachers Retirement System of the State of Kentucky	40,822	$1.88M
Thrivent Financial for Lutherans	37,950	$1.75M
Tudor Investment Corp Et Al	36,919	$1.70M
Ergoteles LLC	26,662	$1.23M
Renaissance Technologies LLC	19,600	$904.0K
Voloridge Investment Management, LLC	19,027	$877.7K
Gotham Asset Management, LLC	15,822	$729.9K
Swedbank AB	13,411	$618.6K
Squarepoint Ops LLC	11,558	$533.2K
Verition Fund Management LLC	7,507	$346.3K
Dynamic Technology Lab Private Ltd	7,060	$326.0K
Linden Thomas Advisory Services, LLC	6,172	$284.7K
PEAK6 Investments LLC	5,999	$276.7K
Vident Investment Advisory, LLC	5,893	$271.8K
Bridgefront Capital, LLC	5,702	$263.0K
Martingale Asset Management L P	5,406	$249.4K
Bank of Montreal	4,739	$229.1K
Fox Run Management, L.L.C.	4,887	$225.4K
Prelude Capital Management, LLC	4,788	$220.9K
ProShare Advisors LLC	4,762	$219.7K
Maryland State Retirement & Pension System	4,688	$216.3K
M&T Bank Corp	4,474	$206.0K
National Bank of Canada	4,063	$189.6K
Acadian Asset Management LLC	1,940	$88.0K
AdvisorNet Financial, Inc	1,500	$69.2K
JJJ Advisors Inc.	105	$4.84K
Parkside Financial Bank & Trust	80	$3.69K
EverSource Wealth Advisors, LLC	25	$1.15K
Proequities, Inc.	13	$599
Versant Capital Management, Inc	12	$554

Not filed for Q3 2023 yet (1)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RARE in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Pictet Asset Management SA	582,976	$26.9M